Re (RMAX) EBITDA (2012 - 2026)

Re (RMAX) has reported EBITDA for 15 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 85.55% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was $23.7 million, a 42.55% decrease from a year earlier, with the FY2025 full-year figure at $49.4 million, up 16.12% from the prior year.
• EBITDA was $2.1 million for Q2 2026 at Re, up from -$7.2 million in the prior quarter.
• Over five years, EBITDA peaked at $18.9 million in Q3 2025 and troughed at -$21.0 million in Q3 2023.
• A 5-year average of $6.4 million and a median of $7.3 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA sank 501.11% in 2023 and jumped 175.3% in 2024, its largest moves.
• Over 5 years, EBITDA stood at $8.5 million in 2022, then sank by 214.58% to -$9.7 million in 2023, then soared by 150.22% to $4.9 million in 2024, then soared by 103.61% to $9.9 million in 2025, then plunged by 78.67% to $2.1 million in 2026.
• The last three EBITDA figures came in at $2.1 million (Q2 2026), -$7.2 million (Q1 2026), and $9.9 million (Q4 2025), per Business Quant data.